Dramamine Chewable Dimenhydrinate Tablet, Chewable
Product Images NDC 50269-525

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dramamine Chewable Dimenhydrinate (NDC 50269-525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jc World Bell Wholesale Co., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inner Package (Inner Package)

Dramamine Chewable Dimenhydrinate 50 mg orange flavored tablets packaging label. The front displays the product name "Dramamine motion sickness" with active ingredient Dimenhydrinate 50 mg per chewable tablet. It includes drug facts covering purpose and use related to motion sickness symptoms. The back panel continues drug facts with warnings, directions, inactive ingredients, storage instructions, and contact information. Labeler is JC World Bell Wholesale Co., Inc.*

FDA Label Image

Outer Package (Outer Package)

Dramamine Chewable Dimenhydrinate 50 mg tablet carton label for motion sickness. The orange and yellow packaging indicates each chewable tablet contains 50 mg dimenhydrinate as an antiemetic. The carton holds 20 packets with 2 orange flavored chewable tablets each, distributed by JC World Bell Wholesale Co., Inc. Drug Facts and usage directions appear on one side panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.